# Belite Bio (BLTE) — Analyst Forecast

BLTE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/blte/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 9 | 0 | 0 | 9 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $206.00 | $251.60 | $303.00 | 5 |

Last price $152.62 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $245.00 |
| Sep 9, 2026 | Mizuho | Maintained | Outperform | $234.00 |
| Sep 8, 2026 | HC Wainwright & Co. | Maintained | Buy | $245.00 |
| Sep 4, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $303.00 |
| Aug 14, 2026 | Cantor Fitzgerald | Maintained | Overweight | $270.00 |
| Aug 14, 2026 | Morgan Stanley | Maintained | Overweight | $206.00 |
| Aug 12, 2026 | HC Wainwright & Co. | Maintained | Buy | $214.00 |
| Jun 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $200.00 |
| May 26, 2026 | Mizuho | Maintained | Outperform | $215.00 |
| May 21, 2026 | HC Wainwright & Co. | Maintained | Buy | $200.00 |
| Apr 22, 2026 | HC Wainwright & Co. | Maintained | Buy | $200.00 |
| Apr 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $200.00 |
| Mar 3, 2026 | Cantor Fitzgerald | Maintained | Overweight | $266.00 |
| Mar 3, 2026 | Morgan Stanley | Maintained | Overweight | $201.00 |
| Mar 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $200.00 |
| Jan 28, 2026 | HC Wainwright & Co. | Maintained | Buy | $185.00 |
| Jan 26, 2026 | B of A Securities | Initiated Coverage | Buy | $195.00 |
| Jan 6, 2026 | Morgan Stanley | Initiated Coverage | Overweight | $191.00 |
| Dec 2, 2025 | Mizuho | Upgraded | Neutral → Outperform | $194.00 |
| Dec 1, 2025 | HC Wainwright & Co. | Maintained | Buy | $185.00 |

## Frequently Asked Questions

### What is the price target for BLTE stock?

The average 12-month analyst price target for Belite Bio (BLTE) is $251.60, with a high estimate of $303.00 and a low of $206.00, across 5 analysts.

### Is BLTE a buy, sell, or hold?

Analysts covering Belite Bio currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BLTE?

The average price target of $251.60 implies 64.85% upside from the last price of $152.62.

### What is the latest analyst rating on BLTE?

On Oct 15, 2026, HC Wainwright & Co. maintained Belite Bio at Buy with a price target of $245.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).